Patent: 10,012,213
✉ Email this page to a colleague
Summary for Patent: 10,012,213
| Title: | System and method for upgrading multivendor wind turbines |
| Abstract: | The present disclosure is directed to a system and method for controlling and/or upgrading aftermarket multivendor wind turbines. The system includes a turbine controller configured to control operations of the wind turbine, a safety device configured to provide a signal indicative of a health status of the safety device, and a secondary controller inserted between the safety device and the turbine controller. The secondary controller is configured to receive the signal from the safety device over a communication interface. As such, if the signal indicates a normal health status, the secondary controller is configured to send the signal to the turbine controller, i.e. maintain normal operation. Alternatively, if the signal indicates a poor health status, the secondary controller is configured to adjust the signal based at least in part on a signal bias to an adjusted signal and to provide the adjusted signal to the turbine controller. |
| Inventor(s): | Chacon; Joseph Lawrence (Greenville, SC), Fish; William Earl (Amsterdam, NY), Pennington; Noah (Simpsonville, SC), Cardinal; Mark Edward (Altamont, NY) |
| Assignee: | General Electric Company (Schenectady, NY) |
| Application Number: | 15/015,451 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,012,213
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Canada Inc. | BAT | botulism antitoxin heptavalent (a, b, c, d, e, f, g) - (equine) | Solution | 125462 | 03/22/2013 | ⤷ Try a Trial | 2040-01-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
